These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12506776)

  • 1. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.
    Targoff IN
    Rheum Dis Clin North Am; 2002 Nov; 28(4):859-90, viii. PubMed ID: 12506776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory myopathies-a review.
    Jones J; Wortmann R
    Clin Rheumatol; 2015 May; 34(5):839-44. PubMed ID: 25681070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.
    Tansley SL; McHugh NJ
    Curr Rheumatol Rep; 2014 Dec; 16(12):464. PubMed ID: 25467551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].
    Kowalska-Oledzka E; Stern LZ
    Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
    Ge Y; Lu X; Peng Q; Shu X; Wang G
    PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre.
    Martel C; Vignaud G; Liozon E; Magy L; Gallouedec G; Ly K; Bezanahary H; Cypierre A; Lapébie FX; Palat S; Gondran G; Jauberteau MO; Fauchais AL
    Clin Exp Rheumatol; 2016; 34(5):918-924. PubMed ID: 27494325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies.
    Miller FW
    Curr Opin Rheumatol; 1991 Dec; 3(6):902-10. PubMed ID: 1772743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
    Mandel DE; Malemud CJ; Askari AD
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert Perspective: Management of Refractory Inflammatory Myopathy.
    Lundberg IE
    Arthritis Rheumatol; 2021 Aug; 73(8):1394-1407. PubMed ID: 33844450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year in review 2018: idiopathic inflammatory myopathies.
    Marasco E; Cioffi E; Cometi L; Valentini V; Zanframundo G; Neri R; Cavagna L; Barsotti S
    Clin Exp Rheumatol; 2018; 36(6):937-947. PubMed ID: 30526764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comprehensive understanding and study on idiopathic inflammatory myopathies to improve its diagnosis and treatment].
    Xie QB; Liu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):792-6. PubMed ID: 24325114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
    Haq SA; Tournadre A
    Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia.
    Tan TC; Wienholt L; Adelstein S
    Int J Rheum Dis; 2016 Oct; 19(10):996-1001. PubMed ID: 26621603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Features of Myositis-Associated Autoantibodies: a Review.
    Gunawardena H
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):45-57. PubMed ID: 26453338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.